Sign in
4

Changes in Ownership

Milestone Pharmaceuticals Inc. Filed Acc 0001209191-23-010705

Options or other derivatives

  • Chief Operating Officer acquired 105,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Nelson Jeffrey Edward Chief Operating Officer 2023-02-16 Grant or award · Employee Stock Option (right to buy) +105,000 105,000 D
Loading xslF345X03/doc4.xml…